Skip to main content

Rallybio Corp

For the period ended Dec 31, 2025. Filed Mar 16, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 16, 2026

RLYB$15.66-0.6%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Table of Contents

Page
PART I.
Item 1.Business1
Item 1A.Risk Factors29
Item 1B.Unresolved Staff Comments84
Item 1C.Cybersecurity84
Item 2.Properties84
Item 3.Legal Proceedings85
Item 4.Mine Safety Disclosure85
PART II.
Item 5.Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities85
Item 6.Reserved86
Item 7.Management’s Discussion and Analysis of Financial Condition and Results of Operations86
Item 7A.Quantitative and Qualitative Disclosures About Market Risk96
Item 8.Financial Statements and Supplementary Data96
Item 9.Changes in and Disagreements With Accountants on Accounting and Financial Disclosure96
Item 9A.Controls and Procedures97
Item 9B.Other Information97
Item 9C.Disclosure Regarding Foreign Jurisdictions that Prevent Inspections97
PART III.
Item 10.Directors, Executive Officers and Corporate Governance98
Item 11.Executive Compensation108
Item 12.Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters115
Item 13.Certain Relationships and Related Transactions, and Director Independence118
Item 14.Principal Accounting Fees and Services119
PART IV
Item 15.Exhibits, Financial Statement Schedules120

v

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.